HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $782,255 | +50.1% | 46,178 | +6.3% | 0.00% | – |
| Q2 2023 | $521,112 | -45.0% | 43,426 | -40.4% | 0.00% | – |
| Q1 2023 | $947,935 | -56.1% | 72,806 | -50.1% | 0.00% | – |
| Q4 2022 | $2,157,777 | -0.8% | 145,993 | -40.6% | 0.00% | – |
| Q3 2022 | $2,175,000 | -26.4% | 245,600 | +4.9% | 0.00% | – |
| Q2 2022 | $2,957,000 | -16.4% | 234,032 | +25.1% | 0.00% | – |
| Q1 2022 | $3,539,000 | -43.9% | 187,035 | +3.9% | 0.00% | -100.0% |
| Q4 2021 | $6,313,000 | -32.8% | 179,944 | -29.9% | 0.00% | 0.0% |
| Q3 2021 | $9,395,000 | +19.5% | 256,624 | +28.2% | 0.00% | 0.0% |
| Q2 2021 | $7,862,000 | +25.3% | 200,179 | -9.9% | 0.00% | 0.0% |
| Q1 2021 | $6,273,000 | -27.4% | 222,067 | -17.8% | 0.00% | 0.0% |
| Q4 2020 | $8,646,000 | +210.1% | 270,016 | +212.7% | 0.00% | 0.0% |
| Q3 2020 | $2,788,000 | +82.1% | 86,344 | +55.5% | 0.00% | – |
| Q2 2020 | $1,531,000 | -18.9% | 55,517 | -47.5% | 0.00% | -100.0% |
| Q1 2020 | $1,888,000 | -42.0% | 105,774 | -18.5% | 0.00% | 0.0% |
| Q4 2019 | $3,253,000 | +572.1% | 129,741 | +378.0% | 0.00% | – |
| Q3 2019 | $484,000 | -8.3% | 27,144 | +13.2% | 0.00% | – |
| Q2 2019 | $528,000 | -58.4% | 23,988 | -42.2% | 0.00% | – |
| Q1 2019 | $1,269,000 | +5.5% | 41,492 | -20.4% | 0.00% | – |
| Q4 2018 | $1,203,000 | +1056.7% | 52,099 | +1515.0% | 0.00% | – |
| Q3 2018 | $104,000 | -80.7% | 3,226 | -81.9% | 0.00% | – |
| Q2 2018 | $538,000 | +61.1% | 17,849 | +57.6% | 0.00% | – |
| Q1 2018 | $334,000 | +6580.0% | 11,329 | +8482.6% | 0.00% | – |
| Q4 2017 | $5,000 | -97.1% | 132 | -97.9% | 0.00% | – |
| Q3 2017 | $171,000 | +4.9% | 6,297 | -9.6% | 0.00% | – |
| Q2 2017 | $163,000 | +2616.7% | 6,965 | +2269.0% | 0.00% | – |
| Q1 2017 | $6,000 | -98.6% | 294 | -99.2% | 0.00% | – |
| Q3 2016 | $421,000 | – | 35,349 | +321254.5% | 0.00% | – |
| Q1 2016 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |